Takehiko Doi1, Hiroyuki Shimada2, Hyuma Makizako2, Kota Tsutsumimoto2, Ryo Hotta2, Sho Nakakubo2, Takao Suzuki3. 1. Department of Functioning Activation, Center for Gerontology and Social Science, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan. Japan Society for the Promotion of Science, Tokyo, Japan. Research Institute, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan. take-d@ncgg.go.jp. 2. Department of Functioning Activation, Center for Gerontology and Social Science, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan. 3. Research Institute, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan.
Abstract
BACKGROUND: Disability is a crucial health problem in aging. Identifying a biological contributory factor would be useful. Serum insulin-like growth factor-1 (IGF-1) plays an important role in the endocrine system and is associated with frailty. However, there is no consensus about the relationship between IGF-1 and disability. This study aimed to examine whether IGF-1 related to incident disability among older adults. METHODS: The study included 4,133 older adults (mean age, 71.8±5.4 years) who were participants in the "Obu Study of Health Promotion for the Elderly" cohort study. We collected information on demographic variables, measured gait speed, Mini Mental State Examination score, and serum IGF-1 at baseline. During follow-up, incident disability was monitored by Long-Term Care Insurance certification. RESULTS: Disability was observed in 212 participants during a mean follow-up duration period of 29.2 months. A log rank test indicated that lower levels of serum IGF-1 were related to incident disability (p = .004). A Cox hazard regression showed a lower quartile in IGF-1 related to disability compared with the highest quartile (Q4), even when adjusting for covariates including gait speed and Mini Mental State Examination score (Q1: hazard ratio = 1.72, 95% confidence intervals: 1.06-2.81; Q2: hazard ratio = 1.64, 95% confidence intervals: 0.99-2.71; Q3: hazard ratio = 1.31, 95% confidence intervals: 0.76-2.25). In the analysis, stratified by sex, there was also significant relationship between IGF-1 and disability among women, but not men. CONCLUSIONS: Lower serum IGF-1 was independently related to disability among older adults.
BACKGROUND:Disability is a crucial health problem in aging. Identifying a biological contributory factor would be useful. Serum insulin-like growth factor-1 (IGF-1) plays an important role in the endocrine system and is associated with frailty. However, there is no consensus about the relationship between IGF-1 and disability. This study aimed to examine whether IGF-1 related to incident disability among older adults. METHODS: The study included 4,133 older adults (mean age, 71.8±5.4 years) who were participants in the "Obu Study of Health Promotion for the Elderly" cohort study. We collected information on demographic variables, measured gait speed, Mini Mental State Examination score, and serum IGF-1 at baseline. During follow-up, incident disability was monitored by Long-Term Care Insurance certification. RESULTS:Disability was observed in 212 participants during a mean follow-up duration period of 29.2 months. A log rank test indicated that lower levels of serum IGF-1 were related to incident disability (p = .004). A Cox hazard regression showed a lower quartile in IGF-1 related to disability compared with the highest quartile (Q4), even when adjusting for covariates including gait speed and Mini Mental State Examination score (Q1: hazard ratio = 1.72, 95% confidence intervals: 1.06-2.81; Q2: hazard ratio = 1.64, 95% confidence intervals: 0.99-2.71; Q3: hazard ratio = 1.31, 95% confidence intervals: 0.76-2.25). In the analysis, stratified by sex, there was also significant relationship between IGF-1 and disability among women, but not men. CONCLUSIONS: Lower serum IGF-1 was independently related to disability among older adults.
Authors: P S van Dam; A Aleman; W R de Vries; J B Deijen; E A van der Veen; E H de Haan; H P Koppeschaar Journal: Growth Horm IGF Res Date: 2000-04 Impact factor: 2.372
Authors: Arny A Ferrando; Melinda Sheffield-Moore; Catherine W Yeckel; Charles Gilkison; Jie Jiang; Alison Achacosa; Steven A Lieberman; Kevin Tipton; Robert R Wolfe; Randall J Urban Journal: Am J Physiol Endocrinol Metab Date: 2002-03 Impact factor: 4.310
Authors: Sean X Leng; Anne R Cappola; Ross E Andersen; Marc R Blackman; Kathleen Koenig; Michael Blair; Jeremy D Walston Journal: Aging Clin Exp Res Date: 2004-04 Impact factor: 3.636
Authors: Laura D Baker; Suzanne M Barsness; Soo Borson; George R Merriam; Seth D Friedman; Suzanne Craft; Michael V Vitiello Journal: Arch Neurol Date: 2012-11
Authors: Andrew J Westwood; Alexa Beiser; Charles Decarli; Tamara B Harris; Tai C Chen; Xue-Mei He; Ronenn Roubenoff; Aleksandra Pikula; Rhoda Au; Lewis E Braverman; Philip A Wolf; Ramachandran S Vasan; Sudha Seshadri Journal: Neurology Date: 2014-04-04 Impact factor: 9.910
Authors: T Doi; H Makizako; K Tsutsumimoto; R Hotta; S Nakakubo; K Makino; T Suzuki; H Shimada Journal: J Nutr Health Aging Date: 2018 Impact factor: 4.075
Authors: Jatupol Kositsawat; Chia-Ling Kuo; Lisa C Barry; David Melzer; Stefania Bandinelli; Luigi Ferrucci; Rong Wu; George A Kuchel Journal: J Gerontol A Biol Sci Med Sci Date: 2020-05-22 Impact factor: 6.053
Authors: Alexandra M V Wennberg; Clinton E Hagen; Mary M Machulda; John H Hollman; Rosebud O Roberts; David S Knopman; Ronald C Petersen; Michelle M Mielke Journal: Neurobiol Aging Date: 2018-02-19 Impact factor: 4.673